Trial · NCT03190694
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Change in 24-hr Proteinuria With Dapagliflozin for Six Weeks Relative to Placebo in Patients With Non-diabetic Kidney Disease and Proteinuria 500 mg/Day on Stable Angiotensin-converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Treatment. | Dapagliflozin 10mg Tablet | -15.04 | 95% Confidence Interval -25.70 to -2.76 | % change from baseline | |
Change in 24-hr Proteinuria With Dapagliflozin for Six Weeks Relative to Placebo in Patients With Non-diabetic Kidney Disease and Proteinuria 500 mg/Day on Stable Angiotensin-converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Treatment. | Placebo Matching Dapagliflozin Tablet | -15.80 | 95% Confidence Interval -26.43 to -3.54 | % change from baseline | |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Glomerular Filtration Rate (GFR) Using Iohexol Clearance | Dapagliflozin 10mg: Tablet | -6.3 | 95% Confidence Interval -8.0 to -4.6 | mL/min per 1.73m2 | |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Glomerular Filtration Rate (GFR) Using Iohexol Clearance | Placebo Matching Dapagliflozin Tablet | 0.3 | 95% Confidence Interval -1.4 to 2.0 | mL/min per 1.73m2 | |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 0 SBP | 127.4 | Standard Deviation 16.44 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 0 SBP | 124.6 | Standard Deviation 13.1 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 3 SBP | 124.3 | Standard Deviation 13.93 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 3 SBP | 121.8 | Standard Deviation 9.9 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 6 SBP | 120.4 | Standard Deviation 13.87 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 6 SBP | 123.2 | Standard Deviation 12.27 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 12 SBP | 125.6 | Standard Deviation 15.86 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 12 SBP | 125.2 | Standard Deviation 14.02 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 15 SBP | 125.0 | Standard Deviation 15.05 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 15 SBP | 122.8 | Standard Deviation 13.20 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 18 SBP | 123.5 | Standard Deviation 10.94 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 18 SBP | 120.9 | Standard Deviation 16.48 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | week 24 SBP | 123.6 | Standard Deviation 14.90 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | week 24 SBP | 123.9 | Standard Deviation 14.67 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Dapagliflozin for 1st 6 Weeks and Matching Placebo for 6 Weeks After 6 Week Washout. | Week 0 DBP | 77.2 | Standard Deviation 8.68 | mm Hg |
| Effect of Dapagliflozin 10 mg/d Compared to Placebo on Systolic/Diastolic Blood Pressure | Placebo for the 1st 6 Weeks and Dapagliflozin for 6 Weeks After 6 Week Washout. | Week 0 DBP | 75.2 | Standard Deviation 7.77 | mm Hg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03190694/results